Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema
Status:
Completed
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
This trial is a randomized, double-blind, two arms, multicenter, Phase III study of Berinert
for treatment of ACE induced Angioedema.
This study should show that Berinert shortens the time to complete resolution of signs and
symptoms of acute ACE-induced angioedema of the upper airway tract compared to placebo when
given on top of standard treatment. This study should also compare the time to onset of
relief as defined by an at least one point reduction on the severity scale of ACE-induced
angioedema with Berinert versus placebo.